POLITICO The silymary plant is a natural remedy for many ailments, including arthritis, arthritis pain, and other joint problems.
But it has a downside.
The herbal ingredient silymus can make patients sick.
But now a new study shows that some of its most powerful compounds can also help fight cancer.
The study, published online Monday by the journal Nature, found that silymbols, a form of the plant used in Chinese medicine and other traditional Chinese practices, had powerful anti-cancer properties when mixed with the herb or other drugs.
Silymbol is one of the main ingredients in the herbal medicine cactus herbal and can be used to treat various types of cancers.
For years, scientists have wondered how cactus herbs are able to help cancer patients.
And some studies have shown that the plant is able to reduce the spread of the human papilloma virus.
But the latest study is the first to test whether the plant has the same potential to fight cancer as it does with other treatments.
“There’s a lot of confusion in the medical community about how it works, and a lot that we need to clarify and explore the more,” said Robert L. McKeown, the senior author of the study.
McKeown is an associate professor of medicine at the University of Arizona.
He and his colleagues found that the herbal drug silymyrrhine and a synthetic version of it, silymesperonin, could fight cancer cells with more potent anti-inflammatory properties than either of the existing anti-tumor drugs.
The study used human cervical cells from patients with cervical cancer to test the herb’s ability to prevent the growth of cells that were resistant to the other two cancer-causing compounds.
The herb’s anti-nausea properties were also found to be powerful.
The researchers noted that the anti-parasitic effect of silymsperonine is similar to that of the compound it replaces, diazepam, which is used to help prevent anxiety and panic attacks.
That means that even in cancer patients, the herb could potentially help relieve nausea and vomiting.
But there are a few caveats.
McLean cautioned that the findings should not be taken to mean that silesiesperonines are the only possible cancer treatment options.
McKeefe noted that several other herbal remedies that have been shown to be effective in other cancers have not been tested yet, such as the herb the researchers used for cancer.
For the study, the researchers looked at cells from human cervical cancers that were treated with two different drugs, both of which have been used to kill cancer cells: the drug prednisolone and the chemotherapy drug carboplatin.
In the prednisone, the cancer cells were grown on a dish and treated with prednisohistamine, a drug used to remove the cancer from the body.
The chemo drug, carboplinc, is the same drug used for treatment of many cancers.
The cancer cells then underwent experiments that mimic what happens in cancer cells when they receive a chemotherapeutic dose of prednisones.
In the cancer experiments, cells were treated for a day and then allowed to grow on the dish for a few more days.
One of the chemotherapies, prednisophine, was used to induce apoptosis, the cell death of the cancer.
But when the cells were allowed to recover and then exposed to a dose of carboplin, they were not allowed to do so.
The cells were then treated with a second drug, predanavir, which inhibits the death of cancer cells.
In this second drug-treated group, cells had to be exposed to the chemoresistant, noncancerous cells from the treated group for about 48 hours.
After a day, the chemoreceptors in the treated cells were killed, as were their DNA and proteins.
The cells were also given anti-nuclear antibody, which blocked DNA damage to prevent tumor growth.
The anti-carcinogenic effect of predanacin is not well understood, but McKeow said that it was possible that the cancerous cells were more responsive to the predanaclone than the chemo-treated cells.
McLean said that siliesperonins have been tested for their ability to kill tumors for a long time, and they are often effective, even in cancers that have not responded to any other drugs yet.
But he cautioned that this study was the first time that silingmarysperonination has been shown in cancer.
“The fact that they were able to use this compound in this way and to have this effect in this number of cancerous cell lines is remarkable,” McKeower said.
“But it still leaves a lot to be desired.
The problem with this study is that we don’t know what it is that this compound is doing.”
For more health news, visit health.latimes.com